Lixin Wan
Impact in
- Molecular Biology top 2%
- Ubiquitin and proteasome pathways
- PI3K/AKT/mTOR signaling in cancer
- Protein Degradation and Inhibitors
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Cancer Research top 2%
Papers in
- Cell Biology 18
- Microtubule and mitosis dynamics 12
-
- Cancer, Hypoxia, and Metabolism 7
- Co-authors
- Wenyi WeiHiroyuki InuzukaDaming GaoZhiwei WangHidefumi FukushimaShavali ShaikQing YinJinfang Zhang
- Journals
- Nature Communications (5 papers)Molecular Cell (5 papers)Cell Research (4 papers)Oncotarget (4 papers)Cell Reports (3 papers)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Lixin Wan
63 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Molecular Biology 3.5k
- Cancer Research 746
- Oncology 1.3k
- Cell Biology 783
- Immunology 450
Countries citing papers authored by Lixin Wan
This map shows the geographic impact of Lixin Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixin Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixin Wan more than expected).
Fields of papers citing papers by Lixin Wan
This network shows the impact of papers produced by Lixin Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixin Wan. The network helps show where Lixin Wan may publish in the future.
Co-authors
The 25 scholars most cited alongside Lixin Wan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2022 | 42 | |
| 4 | 2022 | 96 | |
| 5 | 2021 | 20 | |
| 6 | 2021 | 160 | |
| 7 | 2019 | 52 | |
| 8 | 2019 | 62 | |
| 9 | 2018 | 32 | |
| 10 | 2018 | 37 | |
| 11 | 2018 | 56 | |
| 12 | 2017 | 67 | |
| 13 | 2017 | 74 | |
| 14 | 2016 | 34 | |
| 15 | 2014 | 221 | |
| 16 | 2012 | 125 | |
| 17 | 2012 | 175 | |
| 18 | 2011 | 96 | |
| 19 | 2010 | 74 | |
| 20 | 2009 | 3 |
About Lixin Wan
Lixin Wan is a scholar working on Cell Biology, Cancer Research, Oncology, Molecular Biology and Immunology, having authored 66 papers that have together received 4.3k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (35 papers), Cancer-related Molecular Pathways (16 papers), Microtubule and mitosis dynamics (12 papers), PI3K/AKT/mTOR signaling in cancer (7 papers), Cancer, Hypoxia, and Metabolism (7 papers), Melanoma and MAPK Pathways (6 papers), RNA modifications and cancer (6 papers) and Histone Deacetylase Inhibitors Research (5 papers). The work is most often cited by research in Molecular Biology (3.5k citations), Cancer Research (746 citations), Oncology (1.3k citations), Cell Biology (783 citations) and Immunology (450 citations). Lixin Wan has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Wenyi Wei, Hiroyuki Inuzuka, Daming Gao, Zhiwei Wang, Hidefumi Fukushima, Shavali Shaik, Qing Yin, Jinfang Zhang, Rahim Ullah and Pengda Liu. Their work appears in journals such as Nature Communications, Molecular Cell, Cell Research, Oncotarget and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.